KLDOKALEIDOSCOPE VENTURE CAPITA...

OTC


$ 0.00 (5.56 %)    

QQQ $ 453.99 $ 1.46 (0.32 %)
DIA $ 409.36 $ 2.03 (0.5 %)
SPY $ 546.12 $ 1.45 (0.27 %)
TLT $ 99.97 $ 0.59 (0.59 %)
GLD $ 231.49 $ 0.23 (0.1 %)
$ 0.0019
-- x --
-- x --
-- - --
$ 0.00 - $ 0.00
10,000
na
nm
$ 8.15
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-19-2008 09-30-2008 10-Q
2 08-19-2008 06-30-2008 10-Q
3 05-20-2008 03-31-2008 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 the-week-ahead-in-biotech-april-17-april-23-jj-abbott-earnings-adcom-test-for-tg-therapeutics-and-more

Biotech stocks retreated in the week ending April 14, lock-stepping with the broader market. The news flow was light during the...

 12-health-care-stocks-moving-in-thursdays-after-market-session

Gainers

 12-health-care-stocks-moving-in-thursdays-intraday-session

Gainers

Core News & Articles

Today's 5 Stock Ideas: Twitter (TWTR) - Shares were up ~6% near the $49 level following news Elon Musk made an offer t...

 12-health-care-stocks-moving-in-wednesdays-intraday-session

Gainers

 12-health-care-stocks-moving-in-tuesdays-after-market-session

Gainers

 stocks-that-hit-52-week-lows-on-friday

    During Friday's morning session, 234 stocks hit new 52-week lows.

 kaleido-biosciences-announces-notice-of-voluntary-delisting-of-common-stock

-SEC Filing

 benzingas-top-ratings-upgrades-downgrades-for-april-4-2022

Upgrades

 chardan-capital-downgrades-kaleido-biosciences-to-neutral-lowers-price-target-to-17

Chardan Capital analyst Keay Nakae downgrades Kaleido Biosciences (NASDAQ:KLDO) from Buy to Neutral and lowers the price tar...

 12-health-care-stocks-moving-in-fridays-after-market-session

Gainers CVRx (NASDAQ:CVRX) shares rose 11.6% to $7.2 during Friday's after-market session. The market value of their outst...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION